Alexandre Kaoukhov
About
In The Last Decade
Alexandre Kaoukhov
13 papers receiving 397 citations
Peers
Comparison fields: 5 of 54
- Epidemiology 185
- Dermatology 176
- Physiology 116
- Cell Biology 93
- Pulmonary and Respiratory Medicine 75
Countries citing papers authored by Alexandre Kaoukhov
This map shows the geographic impact of Alexandre Kaoukhov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Kaoukhov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Kaoukhov more than expected).
Fields of papers citing papers by Alexandre Kaoukhov
This network shows the impact of papers produced by Alexandre Kaoukhov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Kaoukhov. The network helps show where Alexandre Kaoukhov may publish in the future.
Co-authorship network of co-authors of Alexandre Kaoukhov
This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Kaoukhov. A scholar is included among the top collaborators of Alexandre Kaoukhov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Kaoukhov. Alexandre Kaoukhov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 12 | |
| 4 | 0 | |
| 5 | 6 | |
| 6 | Efficacy and Safety of Sarecycline, a Novel, Once-Daily, Narrow Spectrum Antibiotic for the Treatment of Moderate to Severe Facial Acne Vulgaris: Results of a Phase 2, Dose-Ranging Study. | 24 |
| 7 | Treatment Response With Once-Daily Topical Dapsone Gel, 7.5% for Acne Vulgaris: Subgroup Analysis of Pooled Data from Two Randomized, Double-Blind Stu. | 8 |
| 8 | Safety and Pharmacokinetics of Once-Daily Dapsone Gel, 7.5% in Patients With Moderate Acne Vulgaris. | 9 |
| 9 | Efficacy, Safety, and Dermal Tolerability of Dapsone Gel, 7.5% in Patients with Moderate Acne Vulgaris: A Pooled Analysis of Two Phase 3 Trials. | 13 |
| 10 | Efficacy and Safety of Once-Daily Dapsone Gel, 7.5% for Treatment of Adolescents and Adults With Acne Vulgaris: First of Two Identically Designed, Large, Multicenter, Randomized, Vehicle-controlled Trials. | 31 |
| 11 | 20 | |
| 12 | Tolérance rénale de la ciclosporine au long cours dans le psoriasis | 0 |
| 13 | 129 | |
| 14 | 159 | |
| 15 | [Renal function during long-term cyclosporin treatment of psoriasis]. | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.